Serum-integrated omics reveal the host response landscape for severe pediatric community-acquired pneumonia
Authors:
Open Access
- 1 March 2023
- journal article
- research article
- Published by Springer Nature in Critical Care
- Vol. 27 (1) , 1-17
Abstract
Objective: Community-acquired pneumonia (CAP) is the primary cause of death for children under five years of age globally. Hence, it is essential to investigate new early biomarkers and potential mechanisms involved in disease severity. Methods: Proteomics combined with metabolomics was performed to identify biomarkers suitable for early diagnosis of severe CAP. In the training cohort, proteomics and metabolomics were performed on serum samples obtained from 20 severe CAPs (S-CAPs), 15 non-severe CAPs (NS-CAPs) and 15 healthy controls (CONs). In the verification cohort, selected biomarkers and their combinations were validated using ELISA and metabolomics in an independent cohort of 129 subjects. Finally, a combined proteomics and metabolomics analysis was performed to understand the major pathological features and reasons for severity of CAP. Results: The proteomic and metabolic signature was markedly different between S-CAPs, NS-CAPs and CONs. A new serum biomarker panel including 2 proteins [C-reactive protein (CRP), lipopolysaccharide (LBP)] and 3 metabolites [Fasciculol C, PE (14:0/16:1(19Z)), PS (20:0/22:6(4Z, 7Z, 10Z, 13Z, 16Z, 19Z))] was developed to identify CAP and to distinguish severe pneumonia. Pathway analysis of changes revealed activation of the cell death pathway, a dysregulated complement system, coagulation cascade and platelet function, and the inflammatory responses as contributors to tissue damage in children with CAP. Additionally, activation of glycolysis and higher levels of nucleotides led to imbalanced deoxyribonucleotide pools contributing to the development of severe CAP. Finally, dysregulated lipid metabolism was also identified as a potential pathological mechanism for severe progression of CAP. Conclusion: The integrated analysis of the proteome and metabolome might open up new ways in diagnosing and uncovering the complexity of severity of CAP.Keywords
Funding Information
- National Key Research and Development Program of China (2021YFC2301101, 2021YFC2301102)
- Capital’s Funds for Health Improvement and Research (2020-4-1143)
This publication has 43 references indexed in Scilit:
- Complement links platelets to innate immunitySeminars in Immunology, 2018
- ApoL1 renal risk variants induce aberrant THP-1 monocyte differentiation and increase eicosanoid production via enhanced expression of cyclooxygenase-2American Journal of Physiology-Renal Physiology, 2018
- Urinary Nucleosides and Deoxynucleosides2018
- Human pyrimidine nucleotide biosynthesis as a target for antiviral chemotherapyCurrent Opinion in Biotechnology, 2017
- Complement-Regulatory Proteins CFHR1 and CFHR3 and Patient Response to Anti-CD20 Monoclonal Antibody TherapyClinical Cancer Research, 2017
- Prognostic significance of platelet count changes during hospitalization for community-acquired pneumoniaPlatelets, 2016
- The return of metabolism: biochemistry and physiology of the pentose phosphate pathwayBiological Reviews, 2014
- Deoxynucleoside stress exacerbates the phenotype of a mouse model of mitochondrial neurogastrointestinal encephalopathyBrain, 2014
- Mfuzz: A software package for soft clustering of microarray dataBioinformation, 2007
- Visualization of human C4b-binding protein and its complexes with vitamin K-dependent protein S and complement protein C4b.Proceedings of the National Academy of Sciences, 1983